AMBROSE KRISTEN (SVP & Chief Accounting Officer) sold 5.9% of their position (671.00 shares) of VERTEX PHARMACEUTICALS INC / MA on the open market
Open‑market sale worth $305.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/19/2025ACC: 0000875320-25-000079
Officer· SVP & Chief Accounting Officer
Since May 2021
-1.24K
Net shares
Net seller
$566.7K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
1.24K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−564.00
Price / share
$463.46
Trade value
$261.39K
% of position
4.7%
2/14/2025
12.03K→11.47K
Common Stock
Direct
Shares
−671.00
Price / share
$455.06
Trade value
$305.35K
% of position
5.9%
2/18/2025
11.47K→10.80K
Total
Net shares
−1.24K
Net value
-$566.74K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/14/2025 | F · Tax Withholding | −564.00 | $463.46 | $261.39K | 4.7% | 12.03K | 11.47K |
| Common Stock Direct | 2/18/2025 | S · Sale | −671.00 | $455.06 | $305.35K | 5.9% | 11.47K | 10.80K |
| Total | −1.24K | -$566.74K | ||||||
Derivative Transactions0
No derivative transactions reported